Perfluoropentane clinical trials
How each study uses perfluoropentane is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the perfluoropentane studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 17 Jul 1998 · EchoGen · EMEA/H/C/000149 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2023 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
NuvOx LLC (4)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test perfluoropentane.
- Dec 2026A Dose Escalation Study of NanO2 in Patients With Mild Respiratory DistressPhase 1 · NuvOx LLC
- Jun 2027A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBMPhase 2 · NuvOx LLC
Studies
Open first, then newest update. How each study uses perfluoropentane is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Dose Escalation Study of NanO2 in Patients With Mild Respiratory DistressRecruitingPhase 1NuvOx LLCNCT06658535Written as dodecafluoropentane (0.025 mL/kg)
- NanO2 for Large Vessel Occlusion StrokeNot yet recruitingPhase 2/3NuvOx LLCNCT05389748Written as dodecafluoropentane emulsion (DDFPe)
- A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBMActive, not recruitingPhase 2NuvOx LLCNCT03862430Written as NanO2TM
- The Effects of NVX-108 as a Radiation Sensitizer in GlioblastomaCompletedPhase 1NuvOx LLCNCT02189109Written as NVX-108
Codes
What other systems call perfluoropentane · ClinicalTrials.gg INT002437
- MeSH (NLM) C008806perfluoropentaneOne source ClinicalTrials.gov
- UNII (FDA) 483AU1Y5CZPERFLENAPENTConfirmed FDA, Wikidata
- RxNorm 2474632One source FDA
- Wikidata Q7168152perfluoropentaneConfirmed FDA, Wikidata
- NCI Thesaurus C87703PerflenapentConfirmed FDA, Wikidata
- DrugBank DB11625One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C008806 | perfluoropentane | One source ClinicalTrials.gov |
| UNII (FDA) | 483AU1Y5CZ | PERFLENAPENT | Confirmed FDA, Wikidata |
| RxNorm | 2474632 | — | One source FDA |
| Wikidata | Q7168152 | perfluoropentane | Confirmed FDA, Wikidata |
| NCI Thesaurus | C87703 | Perflenapent | Confirmed FDA, Wikidata |
| DrugBank | DB11625 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.